Pharmeasy Share Price Today

PharmEasy Unlisted Share Price & API Holding Ltd. - Company Overview   

API Holdings Limited formerly known as API Holdings Private Limited is an unlisted public limited company, incorporated on 31st March 2019.

API Holdings Limited is India's largest digital healthcare platform in terms of the gross merchandise value (GMV) of products and services sold.

The Company is engaged in diversified businesses primarily trading pharmaceutical and cosmetic goods, licensing of internet portals or mobile applications related to sales and distribution of pharmaceutical and cosmetic goods, diagnostic services, teleconsulting, etc.

API Holdings Ltd, the parent company of online pharmacy and health tech platform PharmEasy, which recently withdrew its IPO due to "market conditions and external factors”, recorded a larger loss for FY22 than the previous year. Pharmeasy share price has grown from a distributor of medicinal products to a fully integrated, digital healthcare platform that offers teleconsultation, medical equipment, and pharmaceuticals.

PharmEasy Unlisted Share Price, API Holding Pre IPO Stock Details as of March 31, 2025

API Holding Limited (PharmEasy) Incorporation Details

PharmEasy Board of Directors

Vineet Rai - Independent Director

Subramaniam Somasundaram - Independent Director

Jaydeep Dahyalal Tank - Independent Director

Aditya Puri - Professional Director

Deepak Calian Vaidya - Independent Director

Ankur Nand Thadani - Professional Director

Ashutosh Sharma - Professional Director

Siddharth Bhaskar Shah - Managing Director

Dhaval Shah - Whole Time Director

Dovaldas Buzinskas - Professional Director

Hardik Kishor Dedhia - Whole Time Director

Ranjan Ramdas Pai - Professional director

Shyam Powar - Professional Director

PharmEasy Subsidiary & Associate Companies

PharmEasy Industry Outlook

According to a Red Seer Report, the company has a target addressable market of Rs. 10.4 trillion ($139 billion) as of 2020, which corresponds to the size of the entire Indian Healthcare market in 2020. The target addressable market is expected to grow at a 14% CAGR to reach $20 trillion ($266 billion) by 2025.

Online pharmacy-led play: Online pharmacies, consisting of at-home delivery of prescription medicines, covered 63% of the market pre-COVID in 2019 and held 55% of the market in 2020, despite the disruption in pharma supply. eOTC is the second-largest segment, constituting doorstep delivery of generic medicines and health products. It accounted for 26% of the market share before COVID, which soared to 35% in 2020, owing to the high demand for COVID-related OTC products.

Large headroom ahead: Despite the high growth, digital penetration in health (across pharma, OTC, diagnostics, and consultation) is only at 2%, indicating a very nascent stage of penetration. For example, online pharmacy penetration in India was 2.3% in 2020, significantly lower than in China (10-15%) and the United States (30-35%). 

FAQs on PharmEasy 

Q. What is the face value of API Holdings Ltd (PharmEasy) shares?
Answer: The face value of API Holdings Ltd shares is ₹1 per equity share.

Q. What is the ISIN of PharmEasy shares?
Answer: The ISIN of API Holdings Ltd is INE0DJ201029.

Q. What is the minimum lot size for buying PharmEasy shares through WWIPL?
Answer: The minimum lot size is 10,000 shares, subject to market availability.

Q. Why should I buy PharmEasy shares through WWIPL?
Answer: WWIPL offers transparent pricing, secure transactions, verified transfers, and dedicated support throughout the investment journey.

Q. Is investing in PharmEasy a good idea?
Answer: Investors often evaluate PharmEasy based on its position in India's digital healthcare ecosystem, scale, diagnostics business, and long-term

healthcare consumption trends.

Q. What does API Holdings Ltd (PharmEasy) do?
Answer: API Holdings operates an integrated digital healthcare platform offering online medicine delivery, diagnostics, teleconsultation, and healthcare services across India.

Q. Which businesses operate under API Holdings?
Answer: API Holdings operates PharmEasy and owns a majority stake in Thyrocare Technologies Limited, strengthening its diagnostics presence.

Q. What makes PharmEasy different from traditional pharmacy businesses?
Answer: PharmEasy combines e-pharmacy, diagnostics, and digital healthcare services into a single technology-driven platform.

Q. What are the key growth drivers for PharmEasy?
Answer: Digital healthcare adoption, increasing online medicine purchases, diagnostics growth, preventive healthcare awareness, and higher internet penetration can support future growth.

Q. What factors influence the valuation of PharmEasy shares?
Answer: Revenue growth, profitability, customer retention, market share, cash flows, funding activity, and future IPO expectations are major valuation drivers.

Q. Has PharmEasy filed for an IPO?
Answer: Yes. PharmEasy had filed IPO papers earlier but subsequently withdrew them. Any future IPO will depend on business performance and market conditions.

Q. What are the risks of investing in PharmEasy shares?
Answer: Investors should consider profitability challenges, competition, execution risks, funding dependency, valuation risks, and liquidity constraints associated with unlisted shares.

Q. What should investors evaluate before investing in API Holdings Ltd?
Answer: Investors should assess revenue growth, profitability trends, cash burn, market share, balance sheet strength, and long-term healthcare sector prospects..

Q. What is the total outstanding share capital of PharmEasy?
Answer: API Holdings has approximately 1,703.25 crore outstanding equity shares.

Q. Why do HNIs track PharmEasy before a potential future listing?
Answer: Investors monitor PharmEasy because of its scale, healthcare ecosystem presence, and potential long-term value creation if the business successfully improves profitability.